DIA And FDLI Collaborate On First Comprehensive Conference On Biosimilars Since The Enactment Of BPCIA

DIA And FDLI Collaborate On First Comprehensive Conference On Biosimilars Since The Enactment Of BPCIA
Horsham, PA (Vocus/PRWEB) March 17, 2011 DIA, in cooperation with the Food and Drug Law Institute (FDLI), will host Future of Biosimilars in the US: Legal, Regulatory, Scientific, Regulatory, Clinical and Payer Issues from May 4-5 in North Bethesda, MD. FDA, industry, lawyers, academics, clinicians, payers, and patients will discuss the challenges and opportunities ...